Ultralife Corp. (NASDAQ: ULBI) reported Q2 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $17.3 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.